Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo

Generated: January 23, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073580

« Back to Dashboard

NDA 073580 describes EMVERM, which is a drug marketed by Impax Labs Inc and is included in one NDA. It is available from one supplier. Additional details are available on the EMVERM profile page.

The generic ingredient in EMVERM is mebendazole. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mebendazole profile page.
Summary for 073580
Applicant:Impax Labs Inc
Formulation / Manufacturing:see details
Pharmacology for NDA: 073580
Medical Subject Heading (MeSH) Categories for 073580
Suppliers and Packaging for NDA: 073580
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EMVERM mebendazole TABLET, CHEWABLE;ORAL 073580 ANDA Impax Specialty Pharma 64896-669 64896-669-30 1 BLISTER PACK in 1 CARTON (64896-669-30) > 1 TABLET, CHEWABLE in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, CHEWABLE;ORALStrength100MG
Approval Date:Jan 4, 1995TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Cantor Fitzgerald
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.